Spectral Topography of the Subthalamic Nucleus to Inform Next-Generation Deep Brain Stimulation

Overview

Journal Mov Disord

Date 2023 Mar 29

PMID 36987385

Authors

Alberto Averna

Ines Debove

Andreas Nowacki

Katrin Peterman

Benoit Duchet

Mario Sousa

Elena Bernasconi

Laura Alva

Martin L Lachenmayer

Michael Schuepbach

Claudio Pollo

Paul Krack

Thuy-Anh K Nguyen

Gerd Tinkhauser

Affiliations

Soon will be listed here.

Abstract

Background: The landscape of neurophysiological symptoms and behavioral biomarkers in basal ganglia signals for movement disorders is expanding. The clinical translation of sensing-based deep brain stimulation (DBS) also requires a thorough understanding of the anatomical organization of spectral biomarkers within the subthalamic nucleus (STN).

Objectives: The aims were to systematically investigate the spectral topography, including a wide range of sub-bands in STN local field potentials (LFP) of Parkinson's disease (PD) patients, and to evaluate its predictive performance for clinical response to DBS.

Methods: STN-LFPs were recorded from 70 PD patients (130 hemispheres) awake and at rest using multicontact DBS electrodes. A comprehensive spatial characterization, including hot spot localization and focality estimation, was performed for multiple sub-bands (delta, theta, alpha, low-beta, high-beta, low-gamma, high-gamma, and fast-gamma (FG) as well as low- and fast high-frequency oscillations [HFO]) and compared to the clinical hot spot for rigidity response to DBS. A spectral biomarker map was established and used to predict the clinical response to DBS.

Results: The STN shows a heterogeneous topographic distribution of different spectral biomarkers, with the strongest segregation in the inferior-superior axis. Relative to the superiorly localized beta hot spot, HFOs (FG, slow HFO) were localized up to 2 mm more inferiorly. Beta oscillations are spatially more spread compared to other sub-bands. Both the spatial proximity of contacts to the beta hot spot and the distance to higher-frequency hot spots were predictive for the best rigidity response to DBS.

Conclusions: The spatial segregation and properties of spectral biomarkers within the DBS target structure can additionally be informative for the implementation of next-generation sensing-based DBS. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Citing Articles

Neurophysiological gradient in the Parkinsonian subthalamic nucleus as a marker for motor symptoms and apathy.

Bernasconi E, Amstutz D, Averna A, Fischer P, Sousa M, Debove I NPJ Parkinsons Dis. 2025; 11(1):4.

PMID: 39753562 PMC: 11698975. DOI: 10.1038/s41531-024-00848-2.

Machine learning explains response variability of deep brain stimulation on Parkinson's disease quality of life.

Ferrea E, Negahbani F, Cebi I, Weiss D, Gharabaghi A NPJ Digit Med. 2024; 7(1):269.

PMID: 39354049 PMC: 11445542. DOI: 10.1038/s41746-024-01253-y.

Current and future applications of local field potential-guided programming for Parkinson's disease with the Percept™ rechargeable neurostimulator.

Saengphatrachai W, Jimenez-Shahed J Neurodegener Dis Manag. 2024; 14(5):131-147.

PMID: 39344591 PMC: 11524207. DOI: 10.1080/17582024.2024.2404386.

References

Lange F, Steigerwald F, Engel D, Malzacher T, Neun T, Fricke P . Longitudinal Assessment of Rotation Angles after Implantation of Directional Deep Brain Stimulation Leads. Stereotact Funct Neurosurg. 2020; 99(2):150-158. DOI: 10.1159/000511202. View

Rodriguez-Rojas R, Pineda-Pardo J, Manez-Miro J, Sanchez-Turel A, Martinez-Fernandez R, Del Alamo M . Functional Topography of the Human Subthalamic Nucleus: Relevance for Subthalamotomy in Parkinson's Disease. Mov Disord. 2021; 37(2):279-290. DOI: 10.1002/mds.28862. View

Wang J, Hirschmann J, Elben S, Hartmann C, Vesper J, Wojtecki L . High-frequency oscillations in Parkinson's disease: spatial distribution and clinical relevance. Mov Disord. 2014; 29(10):1265-72. DOI: 10.1002/mds.25962. View

Anso J, Benjaber M, Parks B, Parker S, Oehrn C, Petrucci M . Concurrent stimulation and sensing in bi-directional brain interfaces: a multi-site translational experience. J Neural Eng. 2022; 19(2). PMC: 9095704. DOI: 10.1088/1741-2552/ac59a3. View

Cassidy M, Mazzone P, Oliviero A, Insola A, Tonali P, Di Lazzaro V . Movement-related changes in synchronization in the human basal ganglia. Brain. 2002; 125(Pt 6):1235-46. DOI: 10.1093/brain/awf135. View

Nambu A, Takada M, Inase M, Tokuno H . Dual somatotopical representations in the primate subthalamic nucleus: evidence for ordered but reversed body-map transformations from the primary motor cortex and the supplementary motor area. J Neurosci. 1996; 16(8):2671-83. PMC: 6578767. View

Lopez-Azcarate J, Tainta M, Rodriguez-Oroz M, Valencia M, Gonzalez R, Guridi J . Coupling between beta and high-frequency activity in the human subthalamic nucleus may be a pathophysiological mechanism in Parkinson's disease. J Neurosci. 2010; 30(19):6667-77. PMC: 6632566. DOI: 10.1523/JNEUROSCI.5459-09.2010. View

van Wijk B, Beudel M, Jha A, Oswal A, Foltynie T, Hariz M . Subthalamic nucleus phase-amplitude coupling correlates with motor impairment in Parkinson's disease. Clin Neurophysiol. 2016; 127(4):2010-9. PMC: 4803022. DOI: 10.1016/j.clinph.2016.01.015. View

Telkes I, Viswanathan A, Jimenez-Shahed J, Abosch A, Ozturk M, Gupte A . Local field potentials of subthalamic nucleus contain electrophysiological footprints of motor subtypes of Parkinson's disease. Proc Natl Acad Sci U S A. 2018; 115(36):E8567-E8576. PMC: 6130371. DOI: 10.1073/pnas.1810589115. View

10.

Swann N, de Hemptinne C, Miocinovic S, Qasim S, Wang S, Ziman N . Gamma Oscillations in the Hyperkinetic State Detected with Chronic Human Brain Recordings in Parkinson's Disease. J Neurosci. 2016; 36(24):6445-58. PMC: 5015781. DOI: 10.1523/JNEUROSCI.1128-16.2016. View

11.

Meidahl A, Tinkhauser G, Herz D, Cagnan H, Debarros J, Brown P . Adaptive Deep Brain Stimulation for Movement Disorders: The Long Road to Clinical Therapy. Mov Disord. 2017; 32(6):810-819. PMC: 5482397. DOI: 10.1002/mds.27022. View

12.

Averna A, Marceglia S, Priori A, Foffani G . Amplitude and frequency modulation of subthalamic beta oscillations jointly encode the dopaminergic state in Parkinson's disease. NPJ Parkinsons Dis. 2022; 8(1):131. PMC: 9568523. DOI: 10.1038/s41531-022-00399-4. View

13.

Tinkhauser G, Shah S, Fischer P, Peterman K, Debove I, Nygyuen K . Electrophysiological differences between upper and lower limb movements in the human subthalamic nucleus. Clin Neurophysiol. 2019; 130(5):727-738. PMC: 6487671. DOI: 10.1016/j.clinph.2019.02.011. View

14.

Averna A, Marceglia S, Arlotti M, Locatelli M, Rampini P, Priori A . Influence of inter-electrode distance on subthalamic nucleus local field potential recordings in Parkinson's disease. Clin Neurophysiol. 2021; 133:29-38. DOI: 10.1016/j.clinph.2021.10.003. View

15.

Chen C, Pogosyan A, Zrinzo L, Tisch S, Limousin P, Ashkan K . Intra-operative recordings of local field potentials can help localize the subthalamic nucleus in Parkinson's disease surgery. Exp Neurol. 2006; 198(1):214-21. DOI: 10.1016/j.expneurol.2005.11.019. View

16.

Geng X, Xu X, Horn A, Li N, Ling Z, Brown P . Intra-operative characterisation of subthalamic oscillations in Parkinson's disease. Clin Neurophysiol. 2018; 129(5):1001-1010. PMC: 5884428. DOI: 10.1016/j.clinph.2018.01.075. View

17.

Rappel P, Grosberg S, Arkadir D, Linetsky E, Snineh M, Bick A . Theta-alpha oscillations characterize emotional subregion in the human ventral subthalamic nucleus. Mov Disord. 2019; 35(2):337-343. DOI: 10.1002/mds.27910. View

18.

Darcy N, Lofredi R, Al-Fatly B, Neumann W, Hubl J, Brucke C . Spectral and spatial distribution of subthalamic beta peak activity in Parkinson's disease patients. Exp Neurol. 2022; 356:114150. DOI: 10.1016/j.expneurol.2022.114150. View

19.

Tinkhauser G, Pogosyan A, Tan H, Herz D, Kuhn A, Brown P . Beta burst dynamics in Parkinson's disease OFF and ON dopaminergic medication. Brain. 2017; 140(11):2968-2981. PMC: 5667742. DOI: 10.1093/brain/awx252. View

20.

Rodriguez-Oroz M, Rodriguez M, Guridi J, Mewes K, Chockkman V, Vitek J . The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics. Brain. 2001; 124(Pt 9):1777-90. DOI: 10.1093/brain/124.9.1777. View